| Q47203155 | A systematic methodological review of reported perioperative variables, postoperative outcomes and hernia recurrence from randomised controlled trials of elective ventral hernia repair: clear definitions and standardised datasets are needed |
| Q64227856 | Accreditation and certification requirements for hernia centers and surgeons: the ACCESS project |
| Q38918370 | Chemical component separation: a systematic review and meta-analysis of botulinum toxin for management of ventral hernia |
| Q64228245 | Incisional hernia repair with plication and utilization of Botox injections: First case report from Saudi Arabia for a 19-year-old female |
| Q39553331 | Intra-Abdominal Hypertension and Abdominal Compartment Syndrome after Abdominal Wall Reconstruction: Quaternary Syndromes? |
| Q51462441 | Laparoscopic repair of complex ventral hernia facilitated by pre-operative chemical component relaxation using Botulinum Toxin A. |
| Q64063757 | Limitations of Electromyography in the Assessment of Abdominal Wall Muscle Contractility Following Botulinum Toxin A Injection |
| Q48585340 | Preoperative Botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. |
| Q51276451 | Preoperative chemical component relaxation using Botulinum toxin A: enabling laparoscopic repair of complex ventral hernia. |
| Q49950077 | Preoperative combination of progressive pneumoperitoneum and botulinum toxin type A in patients with loss of domain hernia |
| Q40559581 | Preoperative progressive pneumoperitoneum complementing chemical component relaxation in complex ventral hernia repair. |
| Q47569743 | Proposal for a national triage system for the management of ventral hernias |
| Q63753933 | Short-term safety of preoperative administration of botulinum toxin A for the treatment of large ventral hernia with loss of domain |